Stock Earnings

Question 1

What are Neurocrine Biosciences Inc's key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), Neurocrine Biosciences Inc has a total asset of $3,718, Net profit of $341

Question 2

What are the key financial ratios for NBIX?

Accepted Answer

Neurocrine Biosciences Inc's Current ratio is 3.29, has a Net margin is 14.47, sales per share of $22.7.

Question 3

How is Neurocrine Biosciences Inc's revenue broken down by segment or geography?

Accepted Answer

Currently Neurocrine Biosciences Inc data is not available.

Question 4

Is Neurocrine Biosciences Inc profitable?

Accepted Answer

yes, according to the latest financial statements, Neurocrine Biosciences Inc has a net profit of $341

Question 5

Does Neurocrine Biosciences Inc have any liabilities?

Accepted Answer

yes, Neurocrine Biosciences Inc has liability of 1,129

Question 6

How many outstanding shares for Neurocrine Biosciences Inc?

Accepted Answer

Neurocrine Biosciences Inc has a total outstanding shares of 99.4

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	2,682	2,355	1,887	1,488	1,133	1,045
Revenue Growth (YoY)	20%	25%	27%	31%	8%	33%
Cost of Revenue	43	34	39	23	14	10
Gross Profit	2,638	2,321	1,847	1,465	1,119	1,035
Selling, General & Admin	1,142	1,007	887	751	583	433
Research & Development	943	731	565	463	328	275
Operating Expenses	2,085	1,738	1,452	1,214	911	708
Other Non Operating Income (Expenses)	--	--	--	--	--	--
Pretax Income	628	486	332	213	101	106
Income Tax Expense	200	144	82	59	11	-300
Net Income	428	341	249	154	89	407
Net Income Growth	11%	37%	62%	73%	-78%	1,000%
Shares Outstanding (Diluted)	102.5	103.7	101	98.9	97.9	97.8
Shares Change (YoY)	-2%	3%	2%	1%	0%	2%
EPS (Diluted)	4.18	3.29	2.47	1.56	0.92	4.16
EPS Growth	14%	33%	57.99%	70%	-78%	967%
Free Cash Flow	593	557	361	322	233	217
Free Cash Flow Per Share	5.78	5.37	3.57	3.25	2.37	2.21
Gross Margin	98.35%	98.55%	97.88%	98.45%	98.76%	99.04%
Operating Margin	20.61%	24.75%	20.87%	16.8%	18.27%	31.29%
Profit Margin	15.95%	14.47%	13.19%	10.34%	7.85%	38.94%
Free Cash Flow Margin	22.11%	23.65%	19.13%	21.63%	20.56%	20.76%
EBITDA	582	610	415	265	217	335
EBITDA Margin	21.7%	25.9%	21.99%	17.8%	19.15%	32.05%
D&A For EBITDA	29	27	21	15	10	8
EBIT	553	583	394	250	207	327
EBIT Margin	20.61%	24.75%	20.87%	16.8%	18.27%	31.29%
Effective Tax Rate	31.84%	29.62%	24.69%	27.69%	10.89%	-283.01%

Neurocrine Biosciences Inc (NBIX) Price